FDA Approves Warmer Transport and Storage of Pfizer COVID-19 Vaccine

The U.S. Food and Drug Administration (FDA) is giving the 2 dose Pfizer COVID-19 vaccine new transportation and storage conditions.

This week the agency announced that the Pfizer-BioNTech COVID-19 vaccine could be transported and stored at at warmer temperatures.

Prior to the change, the vaccine was expected to be stored at -122 degrees Fahrenheit, now at -76.

The change comes after Pfizer asked the federal agency to look at new data about their storage. They were able to demonstrate that vials remained undiluted for up to two weeks at standard freezer temperatures.

The change is believed to help reduce the burden of producing ultra-low cold storage equipment and get the vaccine to more sites.